Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Cem, Nazli"'
Publikováno v:
International Journal of the Cardiovascular Academy, Vol 5, Iss 4, Pp 116-120 (2019)
Objective: Rheumatic valvular heart disease (RVHD) is an important health problem in Turkey, as in all developing countries. There is no exact prevalence data for RVHD in Turkey. But according to the Jones criteria, Turkey has a moderate risk for acu
Externí odkaz:
https://doaj.org/article/bd924300272945839d78ef068d49f391
Publikováno v:
International Journal of the Cardiovascular Academy, Vol 4, Iss 2, Pp 28-31 (2018)
Introduction: We compared transcatheter and surgical closure of secundum atrial septal defects (ASDs) in terms of cost in this study. Materials and Methods: Between 2006 and 2015, 291 consecutive patients having secundum ASD, in whom percutaneous or
Externí odkaz:
https://doaj.org/article/cc518c8b592c4c8aa90860829ebb9734
Publikováno v:
International Journal of the Cardiovascular Academy, Vol 4, Iss 1, Pp 15-18 (2018)
In this case, we report a successful closure of secundum atrial septal defect in a 32-year-old female patient with an interrupted inferior vena cava (IVC). Interrupted IVC was detected coincidentally during right heart catheterization. The defect was
Externí odkaz:
https://doaj.org/article/8f332b31a8114f29a985f38c64cf822d
Publikováno v:
International Journal of the Cardiovascular Academy, Vol 4, Iss 1, Pp 1-5 (2018)
Objective: We aimed to determine the prevalence, predictors, and mortality rate of premature clopidogrel discontinuation within 30 days of successful coronary stenting. Methods: All consecutive patients who underwent successful coronary stent implant
Externí odkaz:
https://doaj.org/article/50ae53814d8647b6b653600901f8ff7e
Publikováno v:
Medicine Science, Vol 6, Iss 2, Pp 305-9 (2017)
Coraxel (Alvimedica) stents are among those that contain paclitaxel and differ from other paclitaxel eluting stents (PES) in the amount of drug they contain. In this context, it is not known whether the clinical effects of Coraxel stents are differen
Externí odkaz:
https://doaj.org/article/12608cedeb7547f687cb39497326063c
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 49, Iss 4, Pp 334-338 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the global coronavirus disease 2019 (COVID-19) pandemic. Although the virus predominantly causes respiratory system infection, recent reports have shown that it is also a
Autor:
Barış Ünal, Emre Özdemir, Barış Kılıçaslan, Sıddık Erdogan, Orsan Deniz, Mehmet Sait Coşkun, Cem Barçın, Dayimi Kaya, Gönül Zeren, Can Yücel Karabay, Cem Nazli, Faruk Ertaş, Tuba Ekin, Ibrahim Halil Kurt, Sevgi Özcan, Ertugrul Okuyan, Mehmet Yilmaz
Publikováno v:
Acta Cardiologica. 76:475-485
The objective of this study is to assess the prognostic effects of T ranscatheter aortic valve replacement (TAVR) on the patients with different degrees of left ventricular systolic (LVS) function and severe symptomatic aortic stenosis. Also examines
Autor:
Cem Nazli, Ferhat Siyamend Yurdam, Volkan Emren, Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin
Publikováno v:
Koşuyolu Heart Journal.
Objectives: The aim of this study was to determine the primary etiology of pericardial effusion in patients undergoing percutaneous pericardiocentesis. Possible in-hospital mortality related predictors were also investigated. Patients and Methods: A
Publikováno v:
Selcuk Tip Dergisi. 2:133-136
\n Atriyal septal defekt(ASD) eriskinlerdeki defektlerin de % 30-33’unden sorumludur. Sekundum ASD tedavisinde transkateter tedavi birinci basamak tedavi olarak yer almaktadir. 36 yasinda sekundum ASD tanisi olan hastanin basarili transkateter kapa
Autor:
Ersin Çağrı Şimşek, Cem Nazli, Rahman Bilal Gediz, Sadık Volkan Emren, Fatih Levent, Mustafa Ozan Gürsoy, Uğur Karagöz, Oktay Şenöz, Emre Özdemir
Publikováno v:
Bosnian Journal of Basic Medical Sciences (2019)
An impaired heart rate recovery (HRR) has been associated with increased risk of cardiovascular events, cardiovascular, and all‐cause mortality. However, the diagnostic ability of HRR for the presence and severity of coronary artery disease (CAD) h